Transgene Biotek informs about closure of trading window

30 Jan 2016 Evaluate

Transgene Biotek has informed that the meeting of the Board of Directors of the Company will be held on February 15, 2016, to take on record the unaudited financial results for the quarter ended December 31, 2015; As per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, The Trading Window for transactions in shares of the Company is closed from February 01, 2016 to February 17, 2016, for the purpose of announcement of the Un-audited Financial Results by the Company for the quarter ended on December 31, 2015.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

7.07 0.14 (2.02%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.